Studying the DNA structure of GBM cells, Dr. Gallo and his research team have discovered that GBM stem cells have a characteristic way of packaging their DNA. Armed with this knowledge, Dr. Gallo hopes to develop targeted drugs, capable of altering this DNA packaging to minimize, and one day prevent, the chances of relapse.
Dr. Doug Mahoney’s lab is one of three in the world looking at a new immunotherapy combination that is showing promise for killing cancer.
I wouldn’t be here today if not for that new treatment protocol. It was tough on my body, but it saved me. That treatment would not have been possible without research. It seems almost miraculous when I think about it.
Mason was six that day in January. Telling a six-year-old he has cancer, what cancer is and what could possibly happen to him was an out of body experience for me. He’s six. How is this possible? He is only six. Our world spiraled out of control.
I will never forget that moment, coming out of the MRI suite when the technician directed me toward a room where Shelly was sitting, waiting for me to return. Shelly had already been devastated by the images and what the radiologist had said. The images revealed a massive brain tumour, which we later confirmed as a group 3 metastatic medulloblastoma – one of the worst and most aggressive forms of childhood brain cancer.